Met Life Investment Management, LLC Alaunos Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

49 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.62 - $1.17 $7,502 - $14,158	-12,101 Closed	0 $0
Q4 2021 May 17, 2024	SELL	$1.09 - $1.89 $72,090 - $125,000	-66,138 Reduced 84.53%	12,101 $13,000
Q4 2021 Jun 21, 2023	BUY	$1.09 - $1.89 $13,190 - $22,870	12,101 New	12,101 $13,000
Q4 2021 Mar 22, 2023	SELL	$1.09 - $1.89 $72,090 - $125,000	-66,138 Reduced 84.53%	12,101 $13,000
Q4 2021 Feb 15, 2022	SELL	$1.09 - $1.89 $72,090 - $125,000	-66,138 Reduced 84.53%	12,101 $13,000
Q3 2021 May 17, 2024	BUY	$1.44 - $2.73 $50,862 - $96,426	35,321 Added 82.3%	78,239 $142,000
Q3 2021 Jun 21, 2023	BUY	$1.44 - $2.73 $112,664 - $213,592	78,239 New	78,239 $142,000
Q3 2021 Mar 22, 2023	BUY	$1.44 - $2.73 $50,862 - $96,426	35,321 Added 82.3%	78,239 $142,000
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $50,862 - $96,426	35,321 Added 82.3%	78,239 $142,000
Q2 2021 May 17, 2024	SELL	$2.63 - $3.67 $111,564 - $155,681	-42,420 Reduced 49.71%	42,918 $113,000
Q2 2021 Jun 21, 2023	BUY	$2.63 - $3.67 $112,874 - $157,509	42,918 New	42,918 $113,000
Q2 2021 Mar 22, 2023	SELL	$2.63 - $3.67 $111,564 - $155,681	-42,420 Reduced 49.71%	42,918 $113,000
Q2 2021 Aug 16, 2021	SELL	$2.63 - $3.67 $111,564 - $155,681	-42,420 Reduced 49.71%	42,918 $113,000
Q1 2021 May 17, 2024	BUY	$2.82 - $5.6 $240,653 - $477,892	85,338 New	85,338 $307,000
Q1 2021 Jun 26, 2023	BUY	$2.82 - $5.6 $240,653 - $477,892	85,338 New	85,338 $307 Million
Q1 2021 Mar 22, 2023	BUY	$2.82 - $5.6 $73,111 - $145,185	25,926 Added 43.64%	85,338 $307,000
Q1 2021 May 14, 2021	BUY	$2.82 - $5.6 $73,111 - $145,185	25,926 Added 43.64%	85,338 $307,000
Q4 2020 May 24, 2024	SELL	$2.09 - $3.09 $14,843 - $21,945	-7,102 Reduced 10.68%	59,412 $149,000
Q4 2020 Jun 22, 2023	BUY	$2.09 - $3.09 $124,171 - $183,583	59,412 New	59,412 $149,000
Q4 2020 Mar 22, 2023	SELL	$2.09 - $3.09 $14,843 - $21,945	-7,102 Reduced 10.68%	59,412 $149,000
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $14,843 - $21,945	-7,102 Reduced 10.68%	59,412 $150,000
Q3 2020 May 24, 2024	SELL	$2.39 - $3.43 $74,704 - $107,211	-31,257 Reduced 31.97%	66,514 $168 Million
Q3 2020 Jun 26, 2023	BUY	$2.39 - $3.43 $158,968 - $228,143	66,514 New	66,514 $167,000
Q3 2020 Mar 22, 2023	SELL	$2.39 - $3.43 $74,704 - $107,211	-31,257 Reduced 31.97%	66,514 $167,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $74,704 - $107,211	-31,257 Reduced 31.97%	66,514 $168,000
Q2 2020 May 24, 2024	BUY	$2.2 - $3.71 $215,096 - $362,730	97,771 New	97,771 $321 Million
Q2 2020 Jun 26, 2023	BUY	$2.2 - $3.71 $215,096 - $362,730	97,771 New	97,771 $320,000
Q2 2020 Mar 22, 2023	BUY	$2.2 - $3.71 $29,609 - $49,932	13,459 Added 15.96%	97,771 $320,000
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $29,609 - $49,932	13,459 Added 15.96%	97,771 $321,000
Q1 2020 Jul 12, 2023	BUY	$1.9 - $4.98 $160,192 - $419,873	84,312 New	84,312 $206,000
Q1 2020 Mar 22, 2023	BUY	$1.9 - $4.98 $53,961 - $141,436	28,401 Added 50.8%	84,312 $206,000
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $53,961 - $141,436	28,401 Added 50.8%	84,312 $207,000
Q4 2019 Jul 12, 2023	BUY	$3.95 - $5.35 $220,848 - $299,123	55,911 New	55,911 $263,000
Q4 2019 Mar 22, 2023	SELL	$3.95 - $5.35 $75,362 - $102,072	-19,079 Reduced 25.44%	55,911 $263,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $75,362 - $102,072	-19,079 Reduced 25.44%	55,911 $264,000
Q3 2019 Jul 12, 2023	BUY	$4.13 - $6.94 $309,708 - $520,430	74,990 New	74,990 $320,000
Q3 2019 Mar 22, 2023	BUY	$4.13 - $6.94 $43,827 - $73,647	10,612 Added 16.48%	74,990 $320,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $43,827 - $73,647	10,612 Added 16.48%	74,990 $321,000
Q2 2019 Jul 12, 2023	BUY	$3.98 - $6.2 $298,460 - $464,938	74,990 New	74,990 $437,000
Q1 2019 Jul 13, 2023	BUY	$2.0 - $4.4 $128,756 - $283,263	64,378 New	64,378 $247,000
Q4 2018 Jul 13, 2023	BUY	$1.61 - $3.62 $103,648 - $233,048	64,378 New	64,378 $120,000
Q4 2018 Mar 22, 2023	SELL	$1.61 - $3.62 $55,810 - $125,487	-34,665 Reduced 35.0%	64,378 $120,000
Q4 2018 Feb 14, 2019	SELL	$1.61 - $3.62 $55,810 - $125,487	-34,665 Reduced 35.0%	64,378 $120,000
Q3 2018 Jul 13, 2023	BUY	$2.26 - $3.27 $145,494 - $210,516	64,378 New	64,378 $206,000
Q3 2018 Mar 22, 2023	BUY	$2.26 - $3.27 $223,837 - $323,870	99,043 New	99,043 $316,000
Q3 2018 Nov 14, 2018	BUY	$2.26 - $3.27 $74,699 - $108,083	33,053 Added 50.09%	99,043 $317,000
Q2 2018 Aug 15, 2018	BUY	$3.02 - $4.94 $86,776 - $141,945	28,734 Added 77.13%	65,990 $199,000
Q1 2018 May 15, 2018	SELL	$3.46 - $5.14 $83,451 - $123,971	-24,119 Reduced 39.3%	37,256 $146,000
Q4 2017 Feb 15, 2018	BUY	$4.0 - $6.54 $245,500 - $401,392	61,375	61,375 $254,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $422M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account